These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 20047705)

  • 1. Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data.
    Reis M; Källén B
    Psychol Med; 2010 Oct; 40(10):1723-33. PubMed ID: 20047705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
    Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC
    Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivery outcome in relation to maternal use of some recently introduced antidepressants.
    Lennestål R; Källén B
    J Clin Psychopharmacol; 2007 Dec; 27(6):607-13. PubMed ID: 18004128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec Pregnancy Cohort.
    Bérard A; Zhao JP; Sheehy O
    BMJ Open; 2017 Jan; 7(1):e013372. PubMed ID: 28082367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy outcome after exposure to antidepressants and the role of maternal depression: results from the Norwegian Mother and Child Cohort Study.
    Nordeng H; van Gelder MM; Spigset O; Koren G; Einarson A; Eberhard-Gran M
    J Clin Psychopharmacol; 2012 Apr; 32(2):186-94. PubMed ID: 22367660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy.
    Davis RL; Rubanowice D; McPhillips H; Raebel MA; Andrade SE; Smith D; Yood MU; Platt R;
    Pharmacoepidemiol Drug Saf; 2007 Oct; 16(10):1086-94. PubMed ID: 17729378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study.
    Ban L; Gibson JE; West J; Fiaschi L; Sokal R; Smeeth L; Doyle P; Hubbard RB; Tata LJ
    BJOG; 2014 Nov; 121(12):1471-81. PubMed ID: 24612301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective serotonin reuptake inhibitors and the risk of congenital anomalies: a systematic review of current meta-analyses.
    Uguz F
    Expert Opin Drug Saf; 2020 Dec; 19(12):1595-1604. PubMed ID: 33001713
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of antidepressants during pregnancy and the risk of spontaneous abortion.
    Nakhai-Pour HR; Broy P; Bérard A
    CMAJ; 2010 Jul; 182(10):1031-7. PubMed ID: 20513781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonate characteristics after maternal use of antidepressants in late pregnancy.
    Källén B
    Arch Pediatr Adolesc Med; 2004 Apr; 158(4):312-6. PubMed ID: 15066868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidepressants in pregnancy: a systematic review.
    Udechuku A; Nguyen T; Hill R; Szego K
    Aust N Z J Psychiatry; 2010 Nov; 44(11):978-96. PubMed ID: 21034181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exposure to antidepressants during pregnancy--prevalences and outcomes.
    Jimenez-Solem E
    Dan Med J; 2014 Sep; 61(9):B4916. PubMed ID: 25186551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exposure to mirtazapine during pregnancy: a prospective, comparative study of birth outcomes.
    Djulus J; Koren G; Einarson TR; Wilton L; Shakir S; Diav-Citrin O; Kennedy D; Voyer Lavigne S; De Santis M; Einarson A
    J Clin Psychiatry; 2006 Aug; 67(8):1280-4. PubMed ID: 16965209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SSRI antidepressants and birth defects.
    Prescrire Int; 2006 Dec; 15(86):222-3. PubMed ID: 17167929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations.
    Källén BA; Otterblad Olausson P
    Birth Defects Res A Clin Mol Teratol; 2007 Apr; 79(4):301-8. PubMed ID: 17216624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidepressant use in pregnancy and the risk of cardiac defects.
    Huybrechts KF; Palmsten K; Avorn J; Cohen LS; Holmes LB; Franklin JM; Mogun H; Levin R; Kowal M; Setoguchi S; Hernández-Díaz S
    N Engl J Med; 2014 Jun; 370(25):2397-407. PubMed ID: 24941178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duration of antidepressant use during pregnancy and risk of major congenital malformations.
    Ramos E; St-André M; Rey E; Oraichi D; Bérard A
    Br J Psychiatry; 2008 May; 192(5):344-50. PubMed ID: 18450657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal antidepressant use and risk of congenital malformations: A population-based cohort study.
    Chan JKN; Lee KCK; Wong CSM; Chang WC
    Psychiatry Res; 2024 Sep; 339():116038. PubMed ID: 38889560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidepressant use in pregnancy and severe cardiac malformations: Danish register-based study.
    Kolding L; Ehrenstein V; Pedersen L; Sandager P; Petersen OB; Uldbjerg N; Pedersen LH
    BJOG; 2021 Nov; 128(12):1949-1957. PubMed ID: 34036715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of fetal major malformations: focus on paroxetine.
    Gentile S; Bellantuono C
    J Clin Psychiatry; 2009 Mar; 70(3):414-22. PubMed ID: 19254517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.